Position in PVLA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$5,166,119
+$825,455 QoQ
Shares Held
41,445
-0.1% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PVLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Lisanti Capital Growth, LLC holds $47,213,606 across 13 Biotechnology names. PVLA ranks #3 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
38,612 | $7,708,885 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
75,699 | $5,684,237 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
This page
|
41,445 | $5,166,119 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
18,515 | $4,782,794 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
52,260 | $4,398,724 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
22,075 | $3,731,116 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
39,005 | $3,603,281 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
54,445 | $3,518,780 |
All Filings in PVLA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,166,119 | 41,445 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,340,664 | 41,470 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||